Share
Journal Information
Most often read
1716
Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?Daniel Mazza Matos
Hematol Transfus Cell Ther. 2025;47:3668
1716
Full text access
1494
An approach to autologous stem cell mobilization: trying to define good mobilizersSara Montolio Chiva, Paula Gomez Fernandez, Antonio Manuel Gutiérrez Garcia, Maria del Carmen Ballester Ruiz, Antonia Sampol Mayol, Albert Perez Montaña
Hematol Transfus Cell Ther. 2025;47:3688
1494
Full text access
1451
Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategiesTomasz Sacha, Katarzyna Krawczyk
Hematol Transfus Cell Ther. 2025;47:3675
1451
Full text access
1376
When innovation meets patient blood management – a new way to see bleedingGuilherme Rabello, Rosangela Monteiro, Bianca Meneghini, Fabio Biscegli Jatene
Hematol Transfus Cell Ther. 2025;47:3691
1376
Full text access
1232
Is galactomannan a useful tool for triage and diagnosis of oral invasive aspergillosis?Maria Júlia Pagliarone, Lara Maria Alencar Ramos Innocentini, Fernanda Bortolotto, Vanessa Tonetto Marques Galves, Hilton Marcos Alves Ricz, Tatiane Cristina Ferrari, Renato Luiz Guerino Cunha, Belinda Pinto Simões, Leandro Dorigan de Macedo
Hematol Transfus Cell Ther. 2025;47:3687
1232
Full text access
1097
Lower doses of dacarbazine (modified BEACODD) as a safer strategy with equal effectiveness in an intensive treatment protocol of Hodgkin's lymphoma: a preliminary retrospective analysis of a single public center in BrazilLarissa Hilario Dulley, Arthur Gomes Oliveira Braga, Guilherme Garcia Rodrigues, Sergio Costa Fortier, Carlos Sérgio Chiattone, Talita Maira Bueno da Silveira
Hematol Transfus Cell Ther. 2025;47:3682
1097
Full text access
1052
From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapyFrank Nunes, Breno Moreno de Gusmão, Franciely Bueno Wiginesk, Euler Manenti, Juliana Soares, Mizianne Garcia Freitas, Juliane Dantas Seabra-Garcez, Alexandre Manoel Varela, ... Ariane Vieira Scarlatelli Macedo
Hematol Transfus Cell Ther. 2025;47:3693
1052
Full text access
920
Validation of an automated quality control method to test sterility of two advanced therapy medicinal products: Mesenchymal stromal cells and their extracellular vesiclesCarolina Kymie Vasques Nonaka, Zaquer Suzana Munhoz Costa-Ferro, Ana Carolina Palmeira Arraes, Thamires Lopes Weber, Luciana Souza de Aragão França, Katia Nunes Silva, Bruno Solano de Freitas Souza
Hematol Transfus Cell Ther. 2025;47:3727
920
Full text access
826
Complex somatic mutation landscape in myeloid cells in a patient with VEXAS syndrome: First Brazilian case reportFabíola Reis de Oliveira, Adriane Souza Lima, Carlos Roberto Faria, Thaise Oliveira Quaresma, Marcio M. Mourani, Lauro Wichert-Ana, Paulo Louzada, Fernanda Gutierrez-Rodrigues, ... Rodrigo T. Calado
Hematol Transfus Cell Ther. 2025;47:3686
826
Full text access
605
STAT5B::RARα-positive acute promyelocytic leukemia: Role of next generation sequencing in detection of a rare malignancyIndranil Dey, Sushant Vinarkar, Mayur Parihar, Deepak Kumar Mishra
Hematol Transfus Cell Ther. 2025;47:3726
605
Full text access
557
Transmitted blood infections and emerging vector-borne diseases in blood donors in northern PortugalAna Mota, Margarida Fonseca Cardoso
Hematol Transfus Cell Ther. 2025;47:103734
557
Full text access
530
Assessing the role of bronchoscopy in the management of patients with acute leukemia—a transversal study and proposal of evaluationJosé Vanildo Rodrigues de Oliveira, Carlos Wilson de Alencar Cano, José Vivaldo Moreira Feitosa Júnior, Guilherme Carneiro Barreto, Fernanda Rodrigues Mendes, Raphael Costa Bandeira de Melo, Elvira Deolinda Rodrigues Pereira Velloso, Vanderson Rocha, ... Wellington Fernandes da Silva
Hematol Transfus Cell Ther. 2025;47:103741
530
Full text access
460
Impact of blueberry extract on hematological response in phenylhydrazine-induced hemolytic anemiaDaniela Drosdowski, Patrick Türck, Silvio Tasca, Gabriel de Lima Rosa, Edson Fernando Muller Guzzo, Sara Elis Bianchi, Adriana Simon Coitinho, Cristina Campos Carraro, ... Alex Sander da Rosa Araujo
Hematol Transfus Cell Ther. 2025;47:103744
460
Full text access
416
Twice or once a day? Filgrastim dosing schedule for peripheral hematopoietic stem cells mobilizationMehmet Bakırtaş, Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Semih Başcı, Ali Kılınç, Tahir Darçın, Fatma Nurbüke Şarkışla, Derya Şahin, ... Fevzi Altuntaş
Hematol Transfus Cell Ther. 2025;47:103738
416
Full text access
409
Effect of blood groups on acquired and congenital thrombotic thrombocytopenic purpura and clinical correlation: Multi-center Turkish cohort studyCevat İlteriş Kıkılı, Damla Ortaboz, Melek Yanaşık, Muhlis Cem Ar, Sevgi Kalayoğlu Beşışık
Hematol Transfus Cell Ther. 2025;47:3723
409
Full text access
396
Rare case of discrepant ABO typing between mother and newborn caused by para-Bombay AB phenotypeTatiane Aparecida de Paula Vendrame, Giovana Faria Devides, Nayara Morais Silva, Marcela Custódio Mendes, Márcia Léia Morais Sampaio, Marcia Miyuki Nakamura, Greice Ap.Chetta de Klerk, Lilian Castilho, ... Carine Prisco Arnoni
Hematol Transfus Cell Ther. 2025;47:103742
396
Full text access
395
Unraveling thalassemia intermedia: Novel insights of a hemoglobin Jax [HBA2:c.44G>C] and deletional α0-thalassemia interaction phenotypeSitthichai Panyasai, Kanokwan Jaiping, Pisuttinee Khantarag, Patcharee Nochod, Surada Satthakarn
Hematol Transfus Cell Ther. 2025;47:103739
395
Full text access
388
Evaluation of the role of serum soluble ST2 as a diagnostic biomarker for cancer-associated venous thromboembolismEman Mohamed Abdellatif, Emad Hamdy Hamouda Mohammed, Azza Mohamed Amin Darwish
Hematol Transfus Cell Ther. 2025;47:103740
388
Full text access
339
Dysmegakaryopoiesis in myelodysplastic syndrome: Beyond cell dysplasiaMaria Mirele da Silva Ribeiro, Francisco Dário Rocha Filho, Howard Lopes Ribeiro Junior, Priscila da Silva Mendonça, Ronald Feitosa Pinheiro, Silvia Maria Meira Magalhães
Hematol Transfus Cell Ther. 2025;47:3725
339
Full text access
332
Congenital thrombotic thrombocytopenic purpura and human leukocyte antigen analysis–an amazing clueCevat İlteriş Kıkılı, Demet Kıvanç, Hayriye Şentürk Çiftçi, Mustafa M. Özbalak, Mustafa N. Yenerel, Meliha Nalçacı, Fatma S. Oğuz, Sevgi K. Beşışık
Hematol Transfus Cell Ther. 2025;47:103746
332
Full text access
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.